Completed dosing of 115 participants in a bioavailability and bioequivalence (BA/BE) clinical trial in Australia for IHL-42X, an investigational treatment for obstructive sleep apnea in July 2024.
Phase 2b clinical trial of GH001 in patients with treatment ... depression (TRD) (GH001-TRD-201). GH001 is administered on a single dosing day, without mandated in-trial psychotherapeutic intervention ...
He added: “HRT is our recommended first-line treatment for vasomotor symptoms (hot flushes and night sweats), and ... The draft guidance said medics should “consider CBT” for difficulties sleeping, ...
Fu says she thinks it works well enough that it could become a first-line treatment for depression. It could also work as an add-on for people who feel like they’re not getting enough help from ...
Fu says she thinks it works well enough that it could become a first-line treatment for depression. It could also work as an add-on for people who feel like they’re not getting enough help from ...